News | May 05, 2026
Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses
Notice of Compliance from Health Canada enables marketing authorisation for cancer biosimilar in Canadian market
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
Pharma giant targets new standards of care
Subscribe To Our Newsletter & Stay Updated
